Alexandros Makriyannis Selected Research

Alexandros Makriyannis Research Topics

Disease

28	Pain (Aches) 01/2024 - 09/2001
18	Inflammation (Inflammations) 02/2024 - 10/2003
15	Hyperalgesia 03/2024 - 10/2003
12	Obesity 12/2020 - 10/2007
11	Neuralgia (Stump Neuralgia) 01/2022 - 09/2003
11	Hypothermia 10/2018 - 09/2001
9	Neoplasms (Cancer) 12/2022 - 12/2016
8	Substance-Related Disorders (Drug Abuse) 01/2021 - 10/2007
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 03/2008
7	Tobacco Use Disorder (Nicotine Dependence) 01/2019 - 01/2012
6	Catalepsy 01/2024 - 09/2001
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 11/2008
6	Hypersensitivity (Allergy) 01/2021 - 09/2003
4	Neuroinflammatory Diseases 04/2024 - 01/2021
4	Fibrosis (Cirrhosis) 02/2024 - 03/2012
4	Body Weight (Weight, Body) 10/2020 - 12/2007
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 04/2006
4	Weight Loss (Weight Reduction) 12/2016 - 08/2006
4	Nausea 01/2016 - 07/2007
3	Respiratory Insufficiency (Respiratory Failure) 03/2024 - 10/2021
3	Insulin Resistance 10/2020 - 08/2010
3	Vomiting 01/2020 - 12/2007
3	Multiple Sclerosis 01/2018 - 07/2005
3	Seizures (Absence Seizure) 09/2017 - 09/2007
3	Colitis 02/2015 - 11/2009
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2015 - 01/2006
2	Retinal Diseases 10/2023 - 01/2021
2	Triple Negative Breast Neoplasms 12/2022 - 01/2022
2	Carcinogenesis 01/2022 - 02/2019
2	Metabolic Diseases (Metabolic Disease) 01/2021 - 10/2011
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020 - 01/2019
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2019 - 10/2018
2	Abdominal Pain (Pain, Abdominal) 11/2019 - 10/2018
2	Hyperphagia (Overeating) 01/2019 - 10/2011
2	Glaucoma 01/2019 - 07/2005
2	Marijuana Abuse (Cannabis Abuse) 01/2016 - 11/2002
2	Dementia (Dementias) 01/2014 - 11/2008
2	Weight Gain 10/2011 - 12/2007
2	Overweight 03/2009 - 03/2008
2	Immune System Diseases (Immune Disorders) 11/2008 - 03/2008

Drug/Important Bio-Agent (IBA)

42	CannabinoidsIBA 03/2024 - 09/2001
28	EndocannabinoidsIBA 04/2024 - 03/2003
17	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2024 - 07/2005
12	AM 1241IBA 01/2022 - 09/2001
12	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 12/2002
11	AM4113IBA 02/2024 - 12/2007
11	CB2 Cannabinoid ReceptorIBA 01/2022 - 02/2003
10	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 11/2008
10	RimonabantIBA 03/2019 - 02/2004
9	anandamide (arachidonylethanolamide)IBA 01/2023 - 08/2002
9	N-acylethanolaminesIBA 12/2022 - 02/2015
9	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022 - 06/2011
8	Analgesics (Analgesic Drugs)IBA 01/2024 - 02/2003
7	AcidsIBA 12/2022 - 02/2015
6	Opioid Analgesics (Opioids)IBA 10/2022 - 02/2013
6	Morphine (MS Contin)FDA LinkGeneric 10/2022 - 02/2013
6	amidaseIBA 01/2022 - 02/2015
6	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2021 - 08/2002
6	Nicotine FDA Link 01/2020 - 04/2012
5	Cannabinoid Receptor AgonistsIBA 03/2024 - 02/2003
5	Dronabinol (THC)FDA LinkGeneric 03/2024 - 12/2012
5	AM6545IBA 02/2024 - 10/2017
5	EnzymesIBA 01/2021 - 03/2012
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2002
5	LigandsIBA 04/2016 - 03/2008
4	Glycerol (Glycerine)FDA LinkGeneric 04/2024 - 10/2012
4	CytokinesIBA 12/2022 - 03/2012
4	palmidrolIBA 01/2021 - 02/2015
4	LipidsIBA 01/2021 - 08/2010
3	Messenger RNA (mRNA)IBA 03/2024 - 11/2009
3	Monoacylglycerol LipasesIBA 01/2022 - 03/2012
3	methanandamideIBA 10/2021 - 02/2013
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 02/2015
3	N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA 01/2016 - 03/2003
3	3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA 08/2015 - 03/2012
3	AM 251 (AM251)IBA 04/2014 - 12/2007
3	Glycoproteins (Glycoprotein)IBA 01/2014 - 11/2008
3	9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA 08/2013 - 01/2013
2	MonoglyceridesIBA 11/2023 - 01/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2023 - 01/2013
2	AmidesIBA 12/2022 - 01/2013
2	AlbuminsIBA 02/2021 - 10/2017
2	Interleukin-10 (Interleukin 10)IBA 12/2020 - 03/2012
2	Serotonin (5 Hydroxytryptamine)IBA 11/2019 - 10/2018
2	AM9405IBA 11/2019 - 10/2018
2	N- pyridazin- 3- yl- 4- (3- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)benzylidene)piperidine- 1- carboxamideIBA 01/2019 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 02/2013
2	Therapeutic UsesIBA 12/2018 - 10/2011
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 11/2008
2	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2014 - 02/2013
2	iodopravadoline (AM 630)IBA 04/2014 - 11/2009
2	Sulfonic AcidsIBA 01/2014 - 11/2009
2	Mesylates (Mesylate)IBA 02/2013 - 01/2013
2	pyrazoleIBA 02/2013 - 02/2004
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2013 - 08/2006
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2011 - 11/2008

Therapy/Procedure

13	Therapeutics 01/2024 - 09/2003
8	Analgesia 01/2024 - 05/2005
8	Drug Therapy (Chemotherapy) 01/2022 - 03/2008
2	Ligation 01/2019 - 09/2003